XClose

UCL Enterprise

Home
Menu

Archive of News

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>

8 July 2014: Abzena plc, a UCL School of Pharmacy spinout company has raised £20 million in connection with forthcoming admission to AIM

Abzena, a revenue-generating life sciences company providing services and technologies that enable the development of better biopharmaceutical products, has conditionally raised £20 million by way of a placing of 25 million new shares at 80 pence per share (the “Placing Price”) to trading on the AIM market of the London Stock Exchange. More...

<< 2013 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2015 >>